Skip to main content
Premium Trial:

Request an Annual Quote

Enzo Licenses MultiGen's Dx Panel

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Enzo Biochem said today that it has licensed exclusive rights to market MultiGen Diagnostics' antenatal infectious disease tests in New York and non-exclusive rights to the market them in other US territories.

Enzo will validate and seek approval for MultiGen's multiplex Antenatal Infectious Disease panel and for a thrombophilia panel after they clear New York, New Jersey, and CLIA requirements and after it secures third-party reimbursement.

New York City-based Enzo said that it hopes to make the panel available in the second half of this year.

MultiGen's antenatal panel tests for simultaneous infection of certain bacterial, viral, or fungal pathogens using one specimen. The thrombogenic panel detects multiple mutations that can detect if an individual has a genetic predisposition to blood clotting.

MultiGen's DNA sequencing-based technology increases the "accuracy and utility" of its diagnostic tests, MultiGen Founder and President T. Vinayagamoorthy said in a statement.

Financial terms of the agreement were not released.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.